Basic information Safety Supplier Related

Brequinar

Basic information Safety Supplier Related

Brequinar Basic information

Product Name:
Brequinar
Synonyms:
  • Brequinar
  • 6-Fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic acid
  • 6-fluoro-2-(2'-fluorobiphenyl-4-yl)-3-methylquinoline-4-carboxylic acid
  • 6-fluoro-2-(2'-fluorobiphenyl-4-yl)-3-Methylquinoline-4-carboxyl
  • 4-Quinolinecarboxylic acid, 6-fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-Methyl-
  • 6-Fluoro-2-(2'-fluoro-[1,1'-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid
  • Biphenquinate
  • BPQ
CAS:
96187-53-0
MF:
C23H15F2NO2
MW:
375.37
Product Categories:
  • API
Mol File:
96187-53-0.mol
More
Less

Brequinar Chemical Properties

Melting point:
355-357℃ (N,N-dimethylformamide water )
storage temp. 
2-8°C
solubility 
DMSO:25.9(Max Conc. mg/mL);70.0(Max Conc. mM)
form 
powder to crystal
pka
pKa 4.45(H2O t=RT I=0.10) (Uncertain)
color 
White to Light yellow
CAS DataBase Reference
96187-53-0
More
Less

Safety Information

HS Code 
2933.49.7000
More
Less

Brequinar Usage And Synthesis

Uses

Antineoplastic.

Definition

ChEBI: Brequinar is a quinolinemonocarboxylic acid that is quinoline substituted by 2'-fluoro[1,1'-biphenyl]-4-yl, methyl, carboxy and fluoro groups at positions 2, 3, 4, and 6, respectively. It is an inhibitor of dihydroorotate dehydrogenase, an enzyme that is required for de novo pyrimidine biosynthesis. The compound exhibits antineoplastic and antiviral properties. It has a role as an EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor, an immunosuppressive agent, an antineoplastic agent, an antiviral agent, a pyrimidine synthesis inhibitor, an anticoronaviral agent and an antimetabolite. It is a member of biphenyls, a member of monofluorobenzenes, a quinolinemonocarboxylic acid and a monocarboxylic acid. It is a conjugate acid of a brequinar(1-).

Biological Activity

Brequinar exhibits anti-neoplastic activity against refractory solid tumors in human and mouse models. Continuous treatment is required for depletion of pyrimidine pools in the cancer cells and tumor inhibition.', 'Brequinar inhibits dihydroorotate dehydrogenase (DHODH), the fourth enzyme in the de novo pyrimidine biosynthesis pathway, preventing the synthesis of DNA and RNA. Brequinar has recently been found to have antiviral activity against a broad spectrum of viruses including flaviviruses (dengue virus, West Nile virus, yellow fever virus, and Powassan virus) and also a plus-strand RNA alphavirus (Western equine encephalitis virus) and a negative-strand RNA rhabdovirus (vesicular stomatitis virus).

in vivo

Brequinar sodium-treated (10-20 mg/kg/day) mice has a 31% reduction in percentage of packed cell volume compared with untreated BALB/c mice. Brequinar sodium reduces UTP and CTP levels in bone marrow cells by 30 and 25%, respectively. Brequinar sodium (10-20 mg/kg/day) in combination with uridine (1000-2000 mg/kg/day) prevents anemia, and the hematocrits remain at levels (61-63%) comparable with those of untreated controls[3].

BrequinarSupplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
ChemFuture PharmaTech (Jiangsu) Ltd
Tel
5108538618
Email
suger.wang@chemfuture.com
Hangzhou Yuhao Chemical Technology Co., Ltd
Tel
0571-82693216
Email
info@yuhaochemical.com
Shanghai Sphchem Co., Ltd.
Tel
021-56491756 13512199871
Email
2819742715@qq.com
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com